ReviewFrontiers in oncology2021
Adverse Events Following Administration of Anti-CTLA4 Antibody Ipilimumab.
Amirali Karimi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this paperpooled ittrialcites it
ReviewFrontiers in oncology2021
Amirali Karimi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.